维普期刊资源整合服务平台（V6.5）

105篇 您的检索式：作者名="Hammarsten"

选中清除导出查看参考文献查看引证文献引用追踪共6页首页上一页第1页下一页末页 /6 跳转

	题名	作者	年代	出处	被引量
1	Calculated fast-growing benign prostatic hyperplasia-a risk factor for developing clinical prostate cancer显示文摘	Hammarsten J Hogstedt B	2002	Scand J Urol Nephrol2002，36，：	1
2	Prognostic values of NTpro BNP/BNP ratio in comparison with NTpro BNP or BNP alone in elderly patients with chronic heart failure in a 2-year follow up显示文摘	Juliana Jensen Li-Ping Ma Christian Bjurman Ola Hammarsten Michael L.X. Fu	2011	International Journal of Cardiology2011，，1：	1
3	Stromal PDGFRβ expression in prostate tumors and nonmalignant prostate tissue predicts prostate cancer survival显示文摘	Hagglo C Hammarsten P Josefsson A	2010	Plos One2010，5，10：	1
4	Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia显示文摘	Hammarsten J Hogsted B	2001	Eur Urol2001，39，2：	1
5	Urological Aspects of the Metabolic Syndrome显示文摘	Jan Hammarsten Ralph Peeker	2011	Nat Rev Urol2011，8，9：	1
6	Calculated fast2growing benign prostatic hyperplasia risk factor for developing clinical prostate cancer 显示文摘	Hammarsten J Hogstedt B	2002	Scand J Urol Nephrol2002，36，：	1
7	Calculated fast - growing benign prostatic hyperplasia -a risk factor for developing clinical prostate cancer显示文摘	Hammarsten J Hogstedt B	2002	Scand J Urol Nephrol2002，36，5：	1
8	Hyperinsulinacmia as a risk factor fordeveloping benign prostatic hyperplasia 显示文摘	Hammarsten J Hogstcdt B	2001	Eur Urol2001，39，4：	1
9	Clincal, anthropometric, metabolic and insulin profile of men with fast annual growth rates of benign prostatic hyperplasia显示文摘	Hammarsten J Hogstedt B	1998	Blood Pressure1998，8，：	1
10	Hyperinsulinaemia as a risk factor for developing benign prostatic hyperp lasia显示文摘	Hammarsten J Hogstedt B	2001	Euro Urol2001，39，：	1
11	Hyperinsulinaemia : a prospective risk factor for lethal clinical prostate cancer显示文摘	Hammarsten J Hogstedt B	2005	Eur J Cancer2005，41，18：	1
12	Calculated fast-growing benignprostatic hyperplasia-a risk factor for developing clinical prostate cancer 显示文摘	Hammarsten J Hogstedt B	2002	Scand J Urol Nephrol2002，36，5：	1
13	A higher prediagnostic insulin level is a prospective risk factor for incident prostate cancer显示文摘	Hammarsten J Damber J E Peeker R	2010	Cancer Epidemiol2010，34，5：	1
14	Application of extremely compact capillary discharge soft X-ray lasers to dense plasma diagnostics显示文摘	Rocca J J Hammarsten E C Jankowska E	2003	Phys Plasmas2003，10，20：	1
15	Components of metabolic syndrome-risk factors for the development of benign prostatic hyperplasia 显示文摘	Hammarsten J Hogstedt B Hohhuis N	1998	Prostate Cancer Prostatic Dis1998，1，3：	1
16	Calculated fast-growing benign prostatic hyperplasia:a risk factor for developing clinical prostate cancer显示文摘	HAMMARSTEN J HOGSTEDT B GSTED T	2002	Scand J Urol Nephrol2002，36，8：	1
17	Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia显示文摘	Hammarsten J Hogstedt B	2001	Eur Urol2001，39，：	1
18	A high cannabinoid CB(1) receptor immunoreactivity is associated with disease severity and outcome in prostate cancer显示文摘	CHUNG S C HAMMARSTEN P JOSEFSSON A	2009	Eur J Can2009，45，1：	1
19	Hyperinsulinemia as a risk factor for developing benign prostatic hyperplasia 显示文摘	Hammarsten J H6gstedt B	2001	Eur Urol2001，39，2：	1
20	Red blood cell distribution width and its relation to cardiac function and biomarkers in a prospective hospital cohort referred for echocardiography显示文摘	Holmstrom A Sigurjonsdottir R Hammarsten O	2012	Eur J Intern Med2012，23，7：	1

返回顶部每页显示：

共6页首页上一页第1页下一页末页 /6 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示